120 related articles for article (PubMed ID: 1823637)
1. Natural history of islet cell antibodies during the clinical period of type 1 diabetes. High titres at diagnosis are associated with longer persistence.
Goday A; Fernandez J; Gonzalez-Clemente JM; Ferrer J; Usach E; Gomis R; Vilardell E
Diabetes Res; 1991 Aug; 17(4):169-74. PubMed ID: 1823637
[TBL] [Abstract][Full Text] [Related]
2. Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes.
Bonifacio E; Bingley PJ; Shattock M; Dean BM; Dunger D; Gale EA; Bottazzo GF
Lancet; 1990 Jan; 335(8682):147-9. PubMed ID: 1967440
[TBL] [Abstract][Full Text] [Related]
3. Islet autoantibodies, nationality and gender: a multinational screening study in first-degree relatives of patients with Type I diabetes.
Williams AJ; Bingley PJ; Moore WP; Gale EA;
Diabetologia; 2002 Feb; 45(2):217-23. PubMed ID: 11935153
[TBL] [Abstract][Full Text] [Related]
4. Glutamic acid decarboxylase and islet cell antibodies in healthy Estonian children.
Adojaan B; Sabbah E; Vähäsalo P; Akerblom HK; Podar T; Knip M
J Pediatr Endocrinol Metab; 1999; 12(5):667-72. PubMed ID: 10703539
[TBL] [Abstract][Full Text] [Related]
5. Islet cell antibodies in normal French schoolchildren.
Lévy-Marchal C; Tichet J; Fajardy I; Gu XF; Dubois F; Czernichow P
Diabetologia; 1992 Jun; 35(6):577-82. PubMed ID: 1612232
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of the importance of antibodies against islet cells (ICA) and Glutamate Decarboxylase(anti-GAD) for determining prognosis of diabetes type 1 in the Polish population--5 year observation].
Kretowski A; Szelachowska M; Kinalska I
Pol Arch Med Wewn; 1999 Apr; 101(4):323-7. PubMed ID: 10740410
[TBL] [Abstract][Full Text] [Related]
7. Islet cell antibodies as predictive markers for IDDM in children with high background incidence of disease.
Karjalainen JK
Diabetes; 1990 Sep; 39(9):1144-50. PubMed ID: 2200731
[TBL] [Abstract][Full Text] [Related]
8. The natural history of pre-type 1 (insulin-dependent) diabetes mellitus in patients with autoimmune endocrine diseases.
Betterle C; Presotto F; Magrin L; Pedini B; Moro L; Caretto A; Zanchetta R
Diabetologia; 1994 Jan; 37(1):95-103. PubMed ID: 8150236
[TBL] [Abstract][Full Text] [Related]
9. Age, sex and ICA influence on beta-cell secretion during the first year after the diagnosis of type 1 diabetes mellitus.
Montaña E; Fernandez-Castañer M; Rosel P; Gomez J; Soler J
Diabete Metab; 1991; 17(5):460-8. PubMed ID: 1752347
[TBL] [Abstract][Full Text] [Related]
10. The Giessen-Bad Oeynhausen family study: improved prediction of type I diabetes in a low incidence population of relatives using combinations of islet autoantibodies in a dual step model.
Jaeger C; Hatziagelaki E; Stroedter A; Becker F; Scherer S; Petzoldt R; Federlin K; Bretzel RG
Exp Clin Endocrinol Diabetes; 1999; 107(8):496-505. PubMed ID: 10612480
[TBL] [Abstract][Full Text] [Related]
11. Islet-cell antibodies: markers of a more severe insulin-dependent diabetes mellitus?
Montaña E; Goday A; Rosel P; Casamitjana R; Soler J; Gomis R
Diabetes Res; 1989 Aug; 11(4):167-71. PubMed ID: 2625032
[TBL] [Abstract][Full Text] [Related]
12. Relation between course of disease in type 1 diabetes and islet cell antibodies.
Zamaklar M; Jotic A; Lalic N; Lalic K; Rajkovic N; Milicic T
Ann N Y Acad Sci; 2002 Apr; 958():251-3. PubMed ID: 12021117
[TBL] [Abstract][Full Text] [Related]
13. Increased frequency of islet cell antibodies in unaffected brothers of children with type 1 diabetes.
Eskola V; Vähäsalo P; Akerblom HK; Knip M;
Horm Res; 2003; 59(4):195-200. PubMed ID: 12649574
[TBL] [Abstract][Full Text] [Related]
14. Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. The DENIS Study Group. Deutsche Nikotinamid Interventions-Studie.
Seissler J; Morgenthaler NG; Achenbach P; Lampeter EF; Glawe D; Payton M; Christie M; Scherbaum WA
Diabetologia; 1996 Nov; 39(11):1351-6. PubMed ID: 8933004
[TBL] [Abstract][Full Text] [Related]
15. Use of an islet cell antibody assay to identify type 1 diabetic patients with rapid decrease in C-peptide levels after clinical onset. Belgian Diabetes Registry.
Decochez K; Keymeulen B; Somers G; Dorchy H; De Leeuw IH; Mathieu C; Rottiers R; Winnock F; ver Elst K; Weets I; Kaufman L; Pipeleers DG; Gorus FK;
Diabetes Care; 2000 Aug; 23(8):1072-8. PubMed ID: 10937500
[TBL] [Abstract][Full Text] [Related]
16. Islet cell antibodies and beta-cell function in gestational diabetic women: comparison to first-degree relatives of type 1 (insulin-dependent) diabetic subjects.
Mauricio D; Corcoy R; Codina M; Morales J; Balsells M; de Leiva A
Diabet Med; 1995 Nov; 12(11):1009-14. PubMed ID: 8582122
[TBL] [Abstract][Full Text] [Related]
17. Early T-cell defects in pre-type 1 diabetes.
al Sakkaf L; Pozzilli P; Bingley PJ; Lowdell MW; Thomas JM; Bonifacio E; Gale EA; Bottazzo GF
Acta Diabetol; 1992; 28(3-4):189-92. PubMed ID: 1533543
[TBL] [Abstract][Full Text] [Related]
18. Islet cell antibodies and insulin autoantibodies in patients treated with oral hypoglycaemic agents.
Jennings AM; Spencer KM; Dean BM; Wilson RM; Bottazzo GF; Ward JD
Diabet Med; 1989 Jul; 6(5):434-9. PubMed ID: 2527682
[TBL] [Abstract][Full Text] [Related]
19. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives.
Bingley PJ; Christie MR; Bonifacio E; Bonfanti R; Shattock M; Fonte MT; Bottazzo GF; Gale EA
Diabetes; 1994 Nov; 43(11):1304-10. PubMed ID: 7926304
[TBL] [Abstract][Full Text] [Related]
20. Progression to diabetes in relatives with islet autoantibodies. Is it inevitable?
Gardner SG; Gale EA; Williams AJ; Gillespie KM; Lawrence KE; Bottazzo GF; Bingley PJ
Diabetes Care; 1999 Dec; 22(12):2049-54. PubMed ID: 10587841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
